International Trade Law News /title <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"> <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"> <head> <title>International Trade Law News

« Home | EU Rejects Country of Origin Marking Proposals » | Quiet Month in Washington » | WTO to Open Accession Talks With Libya » | BIS Conducts Search of Kentucky Company for Allege... » | Federal Circuit Snuffs Out Prospects of Byrd Amend... » | President Issues Liberia Blocking Order » | Commerce Department Rejects Short Supply Petition ... » | ITC Publishes 2003 Annual Review of U.S. Trade Act... » | WTO Dispute Settlement Body Reviews U.S. Efforts t... » | ITC Adds Features to DataWeb System » 

July 27, 2004 

CancerVax's Efforts to Develop Cuban Cancer Drugs Detailed

The San Diego Union-Tribune today published a good account of CancerVax Corporation's three-year effort to obtain an OFAC license to complete the clinical development of three experimental cancer drugs that were developed in Cuba (see previous article in International Trade Law News).

The article notes that CancerVax "had to persuade and negotiate amid mounting hostilities between the Bush administration and Cuban dictator Fidel Castro" and "hired savvy Washington, D.C., lobbyists, wooed members of Congress and recruited leading cancer researchers to endorse the cause." The complete article can be found at the following link:

www.signonsandiego.com/news/business/biotech/20040727-9999-1b27cancervx.html.


Editor

Subscribe

Enter your e-mail address below to be notified of updates to International Trade Law News (privacy assured).

Powered by FeedBlitz (See Preview)

Search Trade Law News

International Trade Jobs

Archives

Site Feeds and Bookmarks

Import/Export Links